Vertex Pharmaceuticals (VRTX)

Net Receivables

$2.13B

Quarterly · Period ending: · USD

VRTX logo

VRTX Net Receivables

Latest reported$2.13B
VRTX Quarterly Net Receivables ($0.00 → $2.13B)
High-resolution chart · PNG

VRTX net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
2,134,300,000
1,996,100,000
2,052,800,000
1,946,400,000
1,893,500,000
1,805,100,000
1,609,400,000
1,750,600,000
1,656,100,000
1,793,200,000
1,563,400,000
1,538,700,000
1,556,200,000
1,547,800,000
1,442,200,000
1,385,200,000
1,332,900,000
1,292,800,000
1,136,800,000
1,100,372,000
929,142,000
977,551,000
885,400,000
791,917,000
791,768,000
845,269,000
633,518,000
443,315,000
464,900,000
438,297,000
409,688,000
379,755,000
393,439,000
327,294,000
385,992,000
263,493,000
247,949,000
207,955,000
235,483,000
182,229,000
189,356,000
181,878,000
188,520,000
165,272,000
94,519,000
80,332,000
90,057,000
114,308,000
81,842,000
59,858,000
93,476,000
120,281,000
164,866,000
194,054,000
143,250,000
139,629,000
185,618,000
232,228,000
183,135,000
445,661,000
96,016,000
5,594,000
12,529,000
4,964,000
3,548,000
7,876,000
9,601,000
42,956,000
14,762,000
16,702,000
23,489,000
21,966,000
15,365,000
24,825,000
31,320,000
34,658,000
37,189,000
44,099,000
62,923,000
42,614,000
183,668,000
23,779,000
20,595,000
20,764,000
13,941,000
10,866,000
11,891,000
8,480,000
9,939,000
7,937,000
7,324,000
7,850,000
9,720,000
11,925,000
13,200,000
13,100,000
18,056,000
14,342,000
20,265,000
35,925,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.